Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Oncology Institute, Inc.

Equities

TOI

US68236X1000

Healthcare Facilities & Services

End-of-day quote Nasdaq
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
1.15 USD -2.54% Intraday chart for The Oncology Institute, Inc. -3.36% -43.63%
08/04 The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer CI
04/04 The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 714.2 122.8 150.4 85.46 -
Enterprise Value (EV) 1 714.2 108.8 150.4 85.46 85.46
P/E ratio -60.9 x - - - -
Yield - - - - -
Capitalization / Revenue - 0.49 x 0.46 x 0.21 x 0.18 x
EV / Revenue - 0.49 x 0.46 x 0.21 x 0.18 x
EV / EBITDA - -5.22 x -5.83 x -6.29 x 47.6 x
EV / FCF - -1.82 x -3.68 x -2.49 x -4.17 x
FCF Yield - -54.8% -27.2% -40.1% -24%
Price to Book - - - - -
Nbr of stocks (in thousands) 73,249 74,421 73,749 74,313 -
Reference price 2 9.750 1.650 2.040 1.150 1.150
Announcement Date 10/03/22 09/03/23 27/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 252.5 324.2 412.5 482.8
EBITDA 1 - -23.54 -25.8 -13.58 1.797
EBIT 1 - -79.96 -77.02 -18.82 -3.514
Operating Margin - -31.67% -23.75% -4.56% -0.73%
Earnings before Tax (EBT) - - - - -
Net income 1 -10.93 1.657 -83.07 -50.37 -36.22
Net margin - 0.66% -25.62% -12.21% -7.5%
EPS -0.1600 - - - -
Free Cash Flow 1 - -67.28 -40.88 -34.29 -20.49
FCF margin - -26.65% -12.61% -8.31% -4.24%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 10/03/22 09/03/23 27/03/24 - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 64.98 71.42 76.19 80.22 82.04 85.79 95.16 102.5 107.1 107.8
EBITDA 1 - -6.68 -4.641 -7.929 -6.941 -5.35 -6.252 -5.642 -3.144 -1.687 -3.109
EBIT 1 - -20.1 -23.08 -32.87 -14.94 -13.92 -15.29 -6.944 -4.448 -2.998 -4.426
Operating Margin - -30.93% -32.32% -43.14% -18.62% -16.97% -17.82% -7.3% -4.34% -2.8% -4.1%
Earnings before Tax (EBT) - -2.698 - - - - - - - - -
Net income 1 -5.453 -2.674 -9.502 - -16.9 -17.42 -18.75 -14.67 -12.4 -10.94 -12.36
Net margin - -4.12% -13.3% - -21.06% -21.23% -21.86% -15.42% -12.1% -10.22% -11.46%
EPS -0.0600 -0.0300 - - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 09/08/22 09/11/22 09/03/23 10/05/23 08/08/23 08/11/23 27/03/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - 14 - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - -67.3 -40.9 -34.3 -20.5
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - 5.53 4.57 5.16 6.28
Capex / Sales - 2.19% 1.41% 1.25% 1.3%
Announcement Date 10/03/22 09/03/23 27/03/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.15 USD
Average target price
2.5 USD
Spread / Average Target
+117.39%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
THE ONCOLOGY INSTITUTE, INC. Stock The Oncology Institute, Inc.
-43.63% 85.46M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. TOI Stock
  4. Financials The Oncology Institute, Inc.